Global Colorectal Cancer (CRC) is substantial & gr
Post# of 154563
(Total Views: 276)
Posted On: 06/26/2025 8:35:38 PM
Global Colorectal Cancer (CRC) is substantial & growing with a projected value of USD 30.09 Billion by 2033 ...growing @ a CAGR of 4.7% from 2023 to 2030.
It's the 2nd deadliest cancer...with 1 in 25 women and 1 in 23 men estimated to develop CRC during their lifetime.
The biggest players in the space are:
Amgen, Inc.
Bayers AG.
BMS.
Lilly.
Merck & Co., Inc.
F. Hoffman-La Roche Ltd.
Sanofi.
mTNBC in comparison is USD $1.6. Billion (CAGR of 5.2%).
Might have something to do with CRC being front-burnered.
It's the 2nd deadliest cancer...with 1 in 25 women and 1 in 23 men estimated to develop CRC during their lifetime.
The biggest players in the space are:
Amgen, Inc.
Bayers AG.
BMS.
Lilly.
Merck & Co., Inc.
F. Hoffman-La Roche Ltd.
Sanofi.
mTNBC in comparison is USD $1.6. Billion (CAGR of 5.2%).
Might have something to do with CRC being front-burnered.
(5)
(0)